𝔖 Bobbio Scriptorium
✦   LIBER   ✦

G17DT antibodies inhibit growth of a human pancreatic tumour growing in the pancreas of immunodeficient mice

✍ Scribed by Gilliam, Andrew D.; Morris, Teresa M.; Watson, Susan A.

Book ID
124110684
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
191 KB
Volume
120
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anti-gastrin antibodies raised by gastri
Anti-gastrin antibodies raised by gastrimmune inhibit growth of the human colorectal tumour AP5
✍ Susan A. Watson; Dov Michaeli; Steven Grimes; Teresa M. Morris; David Crosbee; M πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 823 KB

The neutralising ability of rabbit anti-gastrin-I 7 (G 17) antiserum raised by Gastrimmune, an immunogen constructed of the N-terminal portion of human G I 7 conjugated to diptheria toxoid (DT), was evaluated. The anti-serum (denoted anti-G I 7 DT) was shown to displace '25[1] G I 7 from the gastrin

Effect of the vascular endothelial growt
Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice
✍ Christiane J. Bruns; Marissa Shrader; Matthew T. Harbison; Charles Portera; Carm πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 768 KB

## Abstract Vascular endothelial growth factor (VEGF) is the major pro‐angiogenic factor for most tumors. VEGF expression has been shown to be associated with a poor prognosis in human pancreatic cancer. The purpose of our study was to determine the effect of blockade of VEGF receptor‐2 activity wi

Combination of a monoclonal anti-phospha
Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice
✍ Adam W. Beck; Troy A. Luster; Andrew F. Miller; Shane E. Holloway; Chris R. Conn πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 277 KB

## Abstract Pancreatic cancer continues to have a dismal prognosis and novel therapy is needed. In this study, we evaluate a promising new target for therapy, phosphatidylserine (PS). PS is an anionic phospholipid located normally on the inner leaflet of the plasma membrane in mammalian cells. In t